Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC

12/02/2021 | 05:29pm EST

Dec 2 (Reuters) - The United States has administered 464,445,580 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 578,263,565 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 462,263,845 vaccine doses the CDC said had gone into arms by Dec. 1 out of 575,721,925 doses delivered.

The agency said 234,269,053 people had received at least one dose while 197,838,728 people are fully vaccinated as of 6:00 a.m. ET on Thursday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

About 43.0 million people received a booster dose of COVID-19 vaccine from either Pfizer or Moderna or J&J. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)


ę Reuters 2021
All news about MODERNA, INC.
06:49aEMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Sid..
RE
06:47aEMA : Assessment of whether vaccination can cause capillary leak syndrome (is ongoing for ..
RE
01/19Prior COVID infection more protective than vaccination during Delta surge, U.S. study f..
RE
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Moderna Price Target to $315 From $313, Maintains Equal Weight R..
MT
01/18Equities Slump Midday After Treasury Yields Touch Two-Year High, Goldman's Earnings Mis..
MT
01/18MIDDAY REPORT : US Stocks Slump After Treasury Yields Touch Two-Year High; Goldman's Earni..
MT
01/18EU regulator finds mRNA COVID-19 shots safe during pregnancy
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 520 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 774 M - -
P/E ratio 2021 6,59x
Yield 2021 -
Capitalization 70 577 M 70 577 M -
EV / Sales 2021 3,47x
EV / Sales 2022 2,36x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 174,07 $
Average target price 273,19 $
Spread / Average Target 56,9%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-31.46%70 577
LONZA GROUP AG-14.10%53 088
IQVIA HOLDINGS INC.-14.84%45 903
SEAGEN INC.-14.26%24 238
ICON PUBLIC LIMITED COMPANY-17.00%20 923
CELLTRION, INC.-15.66%19 573